Heel pain is one of the most frequently encountered complaints in podiatric and orthopaedic medicine. While plantar fasciitis commands the lion’s share of attention in both clinical settings and popular medical literature, a less well-known but clinically important condition lurks beneath the surface — quite literally. Baxter’s neuropathy, also called entrapment of the first branch of the lateral plantar nerve (FBLPN), is a frequently misdiagnosed cause of chronic heel pain that deserves far greater recognition among clinicians and patients alike.
Anatomy: The Hidden Highway
To understand Baxter’s neuropathy, one must first appreciate the intricate anatomy of the heel. The lateral plantar nerve is a terminal branch of the tibial nerve, which itself descends behind the medial malleolus through the tarsal tunnel. Shortly after entering the plantar foot, the lateral plantar nerve gives off its first branch — the nerve to the abductor digiti minimi (the small muscle on the outer edge of the foot). This first branch travels a circuitous and vulnerable route: it passes between the deep fascia of the abductor hallucis muscle medially and the medial border of the quadratus plantae muscle, before turning laterally to reach its target muscle on the outer aspect of the foot.
It is along this relatively narrow corridor that entrapment most commonly occurs. The nerve can be compressed or irritated by several structures: a hypertrophied abductor hallucis muscle, a thickened plantar fascia, a calcaneal spur — particularly a traction spur at the origin of the plantar fascia — or swelling secondary to chronic inflammation. The result is a peripheral neuropathy that produces pain and sometimes neurological symptoms in the heel region.
Prevalence and the Problem of Misdiagnosis
The true prevalence of Baxter’s neuropathy is difficult to establish with certainty, largely because it is so often misidentified as plantar fasciitis. Some studies suggest that FBLPN entrapment may account for approximately 15–20% of cases presenting with chronic heel pain, and it is thought to coexist with plantar fasciitis in a substantial proportion of patients. This overlap creates a diagnostic trap: when a patient with both conditions is treated solely for plantar fasciitis and fails to improve, Baxter’s neuropathy may be the missing piece of the puzzle.
The condition is particularly prevalent in running athletes and middle-aged adults, though it can affect individuals across a wide range of activity levels. Risk factors include pes planus (flat feet), obesity, a history of chronic plantar fasciitis, and biomechanical abnormalities that place excessive stress on the medial heel and plantar structures.
Clinical Presentation: Knowing What to Look For
Clinically, Baxter’s neuropathy presents subtly. Patients typically describe a deep, burning, or aching pain along the medial aspect of the heel, often more diffuse than the classic “first-step pain” of plantar fasciitis. Some report tingling or numbness, though not all do — which further complicates recognition. The pain may worsen with prolonged standing or athletic activity and can radiate proximally toward the ankle or distally along the plantar foot.
The distinguishing physical examination finding is localised tenderness directly over the course of the first branch of the lateral plantar nerve. This point of maximal tenderness is typically found just distal to the medial calcaneal tubercle and slightly more proximal than the classic plantar fasciitis tender spot, which sits at the fascia’s insertion on the heel bone. Percussion of this area — a positive Tinel’s sign — may reproduce a shooting or electric sensation along the nerve’s distribution, offering a valuable clinical clue.
Weakness or atrophy of the abductor digiti minimi muscle can develop in more advanced cases, though this finding is often subtle and missed in routine examination.
Diagnosis: Putting the Pieces Together
Diagnosis is primarily clinical, relying on a thorough history and a careful physical examination. Imaging plays a supportive role rather than a confirmatory one. Plain X-rays may reveal a calcaneal spur, which while not diagnostic, can be suggestive of local structural stress. Magnetic resonance imaging (MRI) is useful for identifying contributing factors such as plantar fascial thickening, soft-tissue masses, or denervation changes — such as oedema or atrophy — within the abductor digiti minimi muscle, the latter being a highly specific indicator of FBLPN entrapment.
Ultrasound-guided diagnostic nerve block using local anaesthetic can serve as both a diagnostic tool and a temporary therapeutic intervention. Resolution of pain following injection strongly supports the diagnosis. Electrodiagnostic studies (nerve conduction studies and electromyography) may demonstrate slowing across the entrapment site or denervation in the abductor digiti minimi, though sensitivity is variable and a normal result does not exclude the diagnosis.
Treatment: A Staged Approach
Management of Baxter’s neuropathy follows a logical progression from conservative to surgical measures. The vast majority of patients respond well to non-operative treatment, which mirrors but extends the standard care for plantar fasciitis.
Conservative measures include activity modification, anti-inflammatory medications, custom orthotics to correct biomechanical factors (particularly medial arch support for pes planus), physical therapy focusing on stretching of the plantar fascia and calf complex, and targeted soft-tissue massage. Corticosteroid injections — guided by ultrasound for precision — can provide significant and sometimes sustained relief by reducing perineural inflammation. Platelet-rich plasma (PRP) injections have emerged as an alternative for patients in whom corticosteroids have failed, with some encouraging early evidence.
When conservative measures are exhausted — typically after six to twelve months — surgical decompression of the nerve becomes a consideration. The procedure involves releasing the deep fascia of the abductor hallucis, decompressing the nerve along its entire course, and occasionally resecting an offending bony spur. Outcomes are generally favourable, with reported success rates of 70–90% in appropriately selected patients. Recovery requires several weeks of protected weight-bearing and a graduated return to activity.
Conclusion: A Condition Worth Knowing
Baxter’s neuropathy is a reminder that heel pain is not a monolithic diagnosis. Failing to recognise the first branch of the lateral plantar nerve as a potential pain generator can lead to prolonged suffering, unnecessary procedures, and frustrated patients. With careful clinical attention — particularly to the precise location of tenderness, the presence of neurological symptoms, and the response to targeted nerve blocks — this condition can be identified and effectively treated. As awareness grows, so too will the number of patients who finally find relief from one of the heel’s best-kept secrets.